European Archives - Page 753 of 996 - European Medical Journal

EMJ

Interview with Almirall Global Marketing Dermatology Director About New Psoriasis Treatment

Members of the EMJ team were delighted to meet Mr Rajesh Gupta, the Global Marketing Dermatology Director of Almirall, S.A. (Barcelona, Spain), for an…

Introducing EMJ Dermatology 5.1

United Kingdom, November 02, 2017: The European Medical Journal welcomes you to the 2017 edition of EMJ Dermatology, complete with a summary of…

EMJ Dermatology 5.1 2017

The European Medical Journal welcomes you to the 2017 edition of EMJ Dermatology, complete with a summary of the 26th European Academy of Dermatology…

New Recommendations for Improving Junior Doctors’ Working Environment

RECOMMENDATIONS for improving the working environment and morale for junior doctors have been published by NHS Improvement in conjunction with the…

Review of the 26th European Academy of Dermatology and Venerology Congress 2017

A review of the 26th European Academy of Dermatology and Venereology (EADV) congress, held from the 13th–17th September 2017

The Associations of Human Leukocyte Antigen Class I and Class II Alleles in Bullous Pemphigoid

Bullous pemphigoid is a complex, multifactorial autoimmune disease characterised by the presence of autoantibodies against BP autoantigens, leading…

Pseudoxanthoma Elasticum

Pseudoxanthoma elasticum (PXE) is an inherited multisystem disorder characterised by pathological calcification of elastic connective tissue.

Innovation That Drives Your Dermatological Future

This symposium is focused on topical therapies in the treatment of psoriasis and the unmet clinical and patient quality of life needs.

The Impact of Air Pollution on Skin and Related Protection By Thermal Spring Water

In epidemiological studies, it has been shown that exposure to airborne, traffic-related particulate matter (PM) is associated with increased skin…

Advancing Science: Driving Progress Today for a Clearer Tomorrow

Dermatologists today have more tools than ever at their disposal for managing psoriasis, including newer-generation biologics, which target molecular…